ATYR vs CLX · rev $190.0K vs P/E 15, rev $7.10B
aTyr Pharma, Inc. (ATYR) versus The Clorox Company (CLX) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
The Clorox Company (CLX) is a household & personal products company listed on US.
Latest reported ATYR revenue for 2025-09-30 was $190.0K. Net income was -$25.7M. ATYR currently screens at market cap $471.7M.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
ATYR currently screens at market cap $471.7M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Not investment advice. Open the ATYR and CLX stock pages for the full models.
Not investment advice.